Cim Investment Management Inc. raised its stake in shares of Lam Research Corporation (NASDAQ:LRCX – Free Report) by 99.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,658 shares of the semiconductor company’s stock after acquiring an additional 9,812 shares during the quarter. Cim Investment Management Inc.’s holdings in Lam Research were worth $1,914,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of LRCX. Brighton Jones LLC raised its stake in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after buying an additional 12,936 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Lam Research in the 1st quarter valued at approximately $245,000. Horizon Investments LLC raised its position in shares of Lam Research by 110.6% during the 1st quarter. Horizon Investments LLC now owns 48,734 shares of the semiconductor company’s stock valued at $3,543,000 after acquiring an additional 25,593 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Lam Research by 39.8% during the first quarter. EverSource Wealth Advisors LLC now owns 5,916 shares of the semiconductor company’s stock worth $430,000 after purchasing an additional 1,685 shares during the last quarter. Finally, American Century Companies Inc. boosted its holdings in Lam Research by 25.3% in the first quarter. American Century Companies Inc. now owns 1,637,458 shares of the semiconductor company’s stock worth $119,043,000 after purchasing an additional 330,629 shares during the period. Institutional investors own 84.61% of the company’s stock.
Analysts Set New Price Targets
LRCX has been the topic of a number of research reports. Cowen reissued a “buy” rating on shares of Lam Research in a report on Thursday, October 23rd. Susquehanna increased their price objective on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research note on Thursday, October 23rd. BNP Paribas Exane raised their target price on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Oppenheimer set a $200.00 target price on Lam Research and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, TD Cowen increased their price target on Lam Research from $145.00 to $170.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $152.87.
Lam Research Stock Performance
LRCX opened at $160.52 on Friday. The company has a current ratio of 2.21, a quick ratio of 1.60 and a debt-to-equity ratio of 0.37. The business’s 50 day moving average is $152.53 and its 200-day moving average is $120.24. The stock has a market cap of $201.62 billion, a PE ratio of 35.36, a price-to-earnings-growth ratio of 1.65 and a beta of 1.77. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $169.69.
Lam Research (NASDAQ:LRCX – Get Free Report) last posted its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The firm’s revenue was up 27.7% compared to the same quarter last year. During the same period last year, the firm earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.
Lam Research Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s payout ratio is currently 22.91%.
Insider Activity at Lam Research
In related news, insider Ava Harter sold 9,010 shares of the stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $157.47, for a total value of $1,418,804.70. Following the completion of the transaction, the insider owned 56,786 shares in the company, valued at $8,942,091.42. This represents a 13.69% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 40,080 shares of the firm’s stock in a transaction dated Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 102,608 shares of company stock worth $14,916,496. 0.31% of the stock is owned by company insiders.
Lam Research Profile
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
See Also
- Five stocks we like better than Lam Research
- Business Services Stocks Investing
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- How to find penny stocks to invest and tradeĀ
- Why Amazon Could Be a $300 Stock Within Weeks
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
